Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01152229 · ClinicalTrials.gov registry record
Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine
A clinical trial, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 300
- Enrollment target
NCT01152229 is a clinical trial that has completed, run by Medstar Health Research Institute. The registered enrollment target is 300 participants.
The verdict
NCT01152229 has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The objective is to describe and quantify levels of platelet reactivity in three different cohorts of patients taking thienopyridine: patients who report nuisance bleeding, patients who report alarming bleeding, and patients who report no nuisance or alarming bleeding. The investigators hypothesize that patients with nuisance or alarming bleeding events on maintenance thienopyridine therapy will have lower levels of platelet reactivity than patients without nuisance or alarming bleeding on thienopyridine therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01152229
The ClinicalTrials.gov registry entry for NCT01152229 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01152229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01152229 about?
NCT01152229 is a clinical study titled "Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine". The objective is to describe and quantify levels of platelet reactivity in three different cohorts of patients taking thienopyridine: patients who report nuisance bleeding, patients who report alarming bleeding, and patients who report no nuisance or alarming bleeding. The investigators hypothesize ...
What is the current status of trial NCT01152229?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2010-04. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT01152229?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.